JCV + patients with inflammatory bowel disease show elevated plasma levels of MIG and SCF

Inflammatory Bowel Diseases

Volumn 18, Issue 6, 2012, Pages 1194-1196

  Comar, Manola ^a   Secchiero, Paola ^b   De Lorenzo, Elisa ^a   Martelossi, Stefano ^a   Tommasini, Alberto ^a   Zauli, Giorgio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYTOKINE; ETANERCEPT; FIBROBLAST GROWTH FACTOR; INFLIXIMAB; INTERLEUKIN 16; INTERLEUKIN 17; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROTEIN MIG; PROTEIN SCF; PROTEIN VP1; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ADULT; ALLOPATHY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DNA ISOLATION; DNA SEQUENCE; ENTERITIS; FEMALE; GENE AMPLIFICATION; GENOTYPE; HEPATITIS; HUMAN; ITALY; JC VIRUS; JUVENILE RHEUMATOID ARTHRITIS; LETTER; LYMPH FOLLICLE; LYMPHOCYTE MIGRATION; MALE; NEUTROPHIL; NONHUMAN; PEDIATRIC WARD; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; ULCERATIVE COLITIS; VIRUS INFECTION; VIRUS LOAD;

ADOLESCENT; ADULT; CHEMOKINE CXCL9; CHILD; DNA, VIRAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MALE; STEM CELL FACTOR; YOUNG ADULT;

EID: 84861332576     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.22953     Document Type: Letter

References (8)

1. Bellizzi A, Barucca V, Fioriti D, et al. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reaction. J Cell Physiol. 2010; 224: 316-326.
2. Coelho TR, Almeida L, Lazo PA,. 2010. JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? Virol J. 2010; 7: 42.
3. Delbue S, Sotgiu G, Fumagalli D, et al. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine. J Neurovirol. 2005; 11: 51-57.
4. Bouchaud G, Mortier E, Flamant M, et al. Interleukin-15 and its soluble receptor mediate the response to infliximab in patients with Crohn's disease. Gastroenterology. 2010; 138: 2378-2387.
5. Gao Q, Hogezand RA, Lamers CB, et al. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Aliment Pharmacol Ther. 2004; 20: 585-592.
6. Hovhannisyan Z, Treatman J, Littman DR, et al. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology. 2011; 140: 957-965.
7. Pariente B, Mocan I, Camus M, et al. Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease. Gastroenterology. 2001; 141: 217-226.
8. Dajotov T, Andersson P, Pjartell A, et al. Human eosinophils produce the T cell-attracting chemokine MIG and IL-10 upon stimulation with IFN-gamma. J Leuk Biol. 2004; 76: 685-691.